Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Medical Devices | Videos
Contract Research & Services
Contract Research
Return to: PBR Home | Contract Research & Services | Contract Research | News
Search Refinements

Contract Research News

View news from other Pharmaceutical sectors:
136-150 of 2107 results
Lilly, ImaginAb enter into preclinical immuno-oncology research deal
By PBR Staff Writer
Eli Lilly and Company has entered into a preclinical research collaboration with ImaginAb to study potential new T-cell-based immuno-oncology therapies.
Contract Research & Services > Contract Research > News
UK’s NICE launches Office for Market Access for faster development of drugs
By PBR Staff Writer
The UK's National Institute for Health and Care Excellence (NICE) has launched its Office for Market Access (OMA) to speed up approvals of drugs and and health technologies in the country.
Contract Research & Services > Contract Research > News
GTx enrolls first patient in Phase II enobosarm trial to treat triple negative breast cancer
By PBR Staff Writer
GTx, a US-based biopharmaceutical company, has enrolled first patient in its Phase II clinical trial of enobosarm (GTx-024) to treat women with advanced, androgen receptor positive (AR+), triple negative breast cancer (TNBC).
Contract Research & Services > Contract Research > News
Vernalis buys US rights of Moxatag from Pragma Pharmaceuticals
By PBR Staff Writer
Vernalis has acquired the US rights of Moxatag amoxicillin extended-release tablets from Pragma Pharmaceuticals.
Contract Research & Services > Contract Research > News
UbiVac forms collaboration with Johnson & Johnson Innovation
UbiVac, a privately held clinical stage Immuno-Oncology company, has formed a collaboration with Janssen Biotech (Janssen), one of the Janssen Pharmaceutical Companies of Johnson & Johnson.
Contract Research & Services > Contract Research > News
Mesoblast's MPC therapy trial reports better cardioprotective effect
By PBR Staff Writer
The Phase 2 trial results of Mesoblast's mesenchymal precursor cell (MPC) therapy claimed to have greatercardioprotective effect in the subset of patients with more advanced heart failure.
Contract Research & Services > Contract Research > News
Novavax secures grant to support RSV F vaccine development
By PBR Staff Writer
The Bill & Melinda Gates Foundation has awarded a grant of about $89m to Novavax for supporting development of the RSV F Vaccine Phase 3 clinical trial in pregnant women.
Contract Research & Services > Contract Research > News
Study finds maintaining healthy DNA delays menopause
An international study of nearly 70,000 women has identified more than forty regions of the human genome that are involved in governing at what age a woman goes through menopause.
Contract Research & Services > Contract Research > News
Novartis unveils results of Phase III pivotal study of Afinitor
Novartis announced results of a Phase III pivotal study showing Afinitor (everolimus) tablets reduced the risk of progression by 52% (hazard ratio [HR] = 0.48; 95% confidence interval [CI], 0.35-0.67; p<0.00001) vs placebo in patients with advanced, progressive, nonfunctional neuroendocrine tumors (NET) of gastrointestinal (GI) or lung origin.
Contract Research & Services > Contract Research > News
Taiho Oncology gets US FDA nod for Lonsurf refractory colorectal cancer drug
By PBR Staff Writer
Taiho Oncology has secured approval from the US Food and Drug Administration (FDA) for Lonsurf (trifluridine and tipiracil) to treat patients with refractory metastatic colorectal cancer (mCRC).
Contract Research & Services > Contract Research > News
RuiYi doses first patient in double-blinded trial of Gerilimzumab to treat arthritis
By PBR Staff Writer
RuiYi has dosed first patient with Gerilimzumab novel monoclonal antibody to treat rheumatoid arthritis (RA) and other autoimmune disorders.
Contract Research & Services > Contract Research > News
NMI TT Pharmaservices opens new branch in Berlin, Germany
NMI TT Pharmaservices has established a new branch at the Bayer HealthCare CoLaborator in Berlin, Germany.
Contract Research & Services > Contract Research > News
H3 Biomedicine, Selvita expand precision cancer medicine alliance
By PBR Staff Writer
H3 Biomedicine and Selvita have extended their partnership to develop breakthrough precision medicines to treat cancer, through September 2016.
Contract Research & Services > Contract Research > News
Nextera forms research collaboration with Johnson & Johnson Innovation
Nextera has entered into a research agreement with Janssen Biotech, one of the Janssen Pharmaceutical Companies of Johnson & Johnson.
Contract Research & Services > Contract Research > News
Clinigen forms alliance with Cumberland Pharmaceuticals
Clinigen Group has agreed to a strategic alliance with Cumberland Pharmaceuticals, a specialty pharmaceutical company focused on hospital acute care.
Contract Research & Services > Contract Research > News
136-150 of 2107 results